Viela Bio: Divestment of Viela shareholding completed
16 March 2021 07:05 GMT AstraZeneca has completed the divestment of its 26.7% ownership in Viela Bio, Inc. (Viela), asView post on CompanyNewsHQ: Divestment of Viela shareholding completed
Read full article »
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Read more